ADRIONNA SIMPSON: Open Payments
NPI 1154960169 · STEARNS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $126 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Indivior Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: FANAPT, BREZTRI, Jornay PM, REXULTI, SUBLOCADE, Rybelsus, MOUNJARO, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
